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Abstract
Purpose The purpose was to investigate precursor lesions of
polypoidal choroidal vasculopathy (PCV).
Methods This cross-sectional study involved 276 unaffected
contralateral eyes from unilateral PCV patients (Group 1),
unilateral typical exudative age-related macular degeneration
(AMD) patients (Group 2), and unilateral epiretinal membrane
patients (Group 3) as age-matched controls. Grayish-yellow
sub-retinal or sub-retinal-pigment-epithelial deposits larger
than 63 μm in size with irregular but discrete margins were
defined as drusen-like deposits (DLDs). The frequencies of
DLDs, drusen, and pigmentary changes in each group were
compared.
Results DLDs larger than 125 μm in size were found more
frequently in Group 1 (19.5 %) than in Groups 2 (3.4 %) and 3
(3.2 %) (p < 0.001). Soft drusen were discovered more fre-
quently in Group 2 eyes than in Groups 1 and 3 (p < 0.001).
Pigmentary changes were found more frequently in Groups 1
and 2 compared to Group 3. Compared with the other groups,
Group 1 manifested a higher frequency of choroidal vascular
hyperpermeability (p < 0.005) and thicker choroid (p < 0.001).
Conclusions The precursor lesions of PCVare different from
those of exudative AMD. DLDs larger than 125 μm and pig-
mentary changes may be early preclinical markers of PCV.
Long-term longitudinal studies are warranted for validation.
Keywords Age-related macular degeneration . Drusen-like
deposit . Pigmentary change . Polypoidal choroidal
vasculopathy
Introduction
Soft drusen and sub-retinal pigmentary changes in the macular
area are well-known clinical markers of early age-related mac-
ular degeneration (AMD). Previous studies such as the Age-
Related Eye Disease Study suggest that the number and size of
soft drusen and pigmentary changes are associated with the
risk of exudative AMD [1–3], and AMD grading systems
based on these findings are currently used as clinical markers.
There is a preponderance of polypoidal choroidal vascu-
lopathy (PCV) among neovascular AMD in Asian patients.
PCV accounts for 54.7 % of the neovascular AMD in a
Japanese study [4]. Recent study has also reported the propor-
tion of PCVamong neovascular AMDs to be different accord-
ing to geographic location, 9 % in Paris, and 48 % in Kyoto
[5]. Because PCV and typical exudative AMD share certain
common environmental risk factors, genetic determinants,
and a similar presentation of serosanguineous maculopathy,
PCV has been categorized as a subtype of AMD [6].
However, PCV shows distinct characteristics from other
neovascular AMD in that it is exclusively accompanied by
multifocal choroidal hyperfluorescence and venous engorge-
ment on indocyanine green angiography (ICGA) [7–10].
Also, subfoveal choroidal thicknesses in eyes with PCV are
much thicker than the eyes with typical exudative AMD [11,
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12]. Furthermore, PCVis characterized by slower progression,
better visual prognosis despite more chronic persistence when
compared with typical exudative AMD [13, 14]. Therefore,
there has been some controversy whether PCV should be cat-
egorized as a subtype of AMD.
The precursor lesion of active PCV is not known. There is
no definite evidence that soft drusen or sub-retinal pigmentary
changes are early lesions of PCV. Previous studies have re-
ported different characteristics between early lesions of PCV
and typical exudative AMD, such as that soft drusen, are
found less frequently, while pigmentary abnormalities only
are found more frequently in PCV than in AMD [6, 15, 16].
Ueta et al., in their fellow eye study of PCV, observed that
retinal pigmentary atrophy was a prevailing finding before the
manifestation of active PCV [15]. However, the significance
of putative risk factors of PCV has not been clearly addressed.
Identifying the early lesion of PCV, which is highly prevalent
in Asians, might contribute to understanding the pathophysi-
ology of PCVand aid in the development of preventive mea-
sures. Studying the contralateral eye of unilaterally active
PCV patients and comparing them with an age-matched con-
trol group of eyes might be one of the measures to investigate
the precursor lesions, because the probability of a PCV patient
developing PCV in the contralateral eye is higher than the
probability of normal age-matched person developing PCV
[4, 7, 15].
This study was conducted to investigate the precursor le-
sions of PCV by studying the uninvolved contralateral eye of
active unilateral PCV patients compared with age-matched
control eyes and the uninvolved contralateral eye of patients
with unilateral typical exudative AMD.
Materials and methods
The study protocol was approved by the Institutional Review
Board of Samsung Medical Center (IRB No. 2015-05-086),
and conformed to the Declaration of Helsinki. Patient records
were anonymized and de-identified prior to analysis.
Study participants
Patients with unilateral PCV who visited one of seven referral
hospitals in Korea from July 2011 to July 2014 were included
in this study. The patients with a unilateral typical exudative
AMD or a unilateral epiretinal membrane (ERM), who visited
Samsung Medical Center during the same period, were also
included for comparison. The patients were divided into three
groups, and the uninvolved contralateral eyes were analyzed.
Group 1 consisted of the contralateral eyes of unilateral PCV
patients, Group 2 consisted of the contralateral eyes of unilat-
eral typical exudative AMDpatients, and Group 3 consisted of
the contralateral eyes of unilateral ERM patients as age-
matched controls (Datasets are included in the S1 appendix).
Retinal specialists at each center reviewed fundus photogra-
phy, spectral-domain optical coherence tomography (OCT),
fluorescein angiography, and confocal indocyanine green an-
giography (ICGA) images of PCV and typical exudative
AMD patients, and the images were reviewed by two separate
retinal specialists (GEC, HYL) in order to confirm the diag-
nosis. Patients that had a concordant diagnosis were included
in the study. When the diagnosis was different among the
reviewers, another retina specialist (SWK) reviewed the im-
ages and discussed the findings until a final diagnosis was
reached and the patient group was determined.
Inclusion criteria were as follows: 50 years of age or older
and a diagnosis of unilateral PCVor typical exudative AMD
or ERM. Patients were excluded if they had an unknown
cause of choroidal neovascularization or a cause other than
age, such as myopia, angioid streaks, trauma, or uveitis.
Other exclusion criteria were as follows: diabetic retinopathy
more severe than moderate nonproliferative diabetic retinop-
athy, central serous chorioretinopathy (CSC), optic atrophy,
pathologic myopia, macular hole, retinal vascular disease,
uveitis, cataract surgery within the previous three months, or
any history of previous vitreoretinal surgery.
A diagnosis of PCV was concluded if sub-retinal reddish-
orange nodules were visible on fundus photography with
polypoidal structures accompanied with a branching vascular
network on ICGA [17]. Typical exudative AMD was diag-
nosed when serous or hemorrhagic exudative change was
present with accompanying drusen or pigmentary changes
on fundus photography, with choroidal neovascularization
confirmed on fluorescein angiography or ICGAwithout find-
ings of PCV or retinal angiomatous proliferation. ERM was
diagnosed when cellophane macular reflex or premacular fi-
brosis was identified on fundoscopy with a hyper reflective
membrane confirmed on OCT.
Fig. 1 Fundus color photographs (a, b), fluorescein (c, d) and
indocyanine green (e, f) angiographs, infrared images (g, h) and optical
coherence tomographs (i, j) of a 58-year-old man with unilateral
polypoidal choroidal vasculopathy. In the right column, the multimodal
images of the left eye with polypoidal choroidal vasculopathy are
demonstrated. In the left column, the multimodal images of the
uninvolved right eye are demonstrated, which represents the eyes in
Group 1. (a) Funduscopic examination reveals drusen-like deposits
(DLD, arrow) of a grayish yellow-colored sub-retinal deposit with
irregular but discrete margins in the parafoveal area. (c, g) Pigmentary
changes (solid arrow heads) adjacent to DLDs visualized by fluorescein
angiography and fundus autofluorescence imaging. (e) Mild choroidal
hyperpermeability and punctate hyperfluorescent spots (open arrow
heads) on indocyanine green angiography. In this case, a DLD is
spatially correlated with punctate hyperfluorescent spots (i) Optical
coherence tomography scanning over the DLD reveals subretinal
deposits, different from that of soft drusen, which usually show dome-
like elevation due to sub-retinal-pigment-epithelial accumulation. The
subfoveal choroidal thickness is 256 μm
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Fundus photography and spectral domain OCT images of
the uninvolved fellow eyes of these patients were collected
and analyzed. In Groups 1 and 2, the ICGA images of the
contralateral eyes were also analyzed. The eyes were analyzed
by two independent masked observers who were blinded to
the diagnosis of the contralateral eye. In cases with disagree-
ment between the two observers, a third independent blinded
observer analyzed the images, and the final analysis was de-
cided based on the majority rule.
Evaluation of color fundus photographs
In fundus photographs, drusen-like deposits (DLD), drusen,
and pigmentary change within 30 to 35 degrees of the fundus
were evaluated. DLD were defined as sub-retinal or sub-
retinal-pigment-epithelial grayish yellow deposits larger than
63 μm in size with irregular but discrete margins (Figs. 1a and
2a, b). The number of patients with DLD in each group was
evaluated, and the proportion of patients with DLD of 125 μm
or larger size was also evaluated in each group. Drusen were
further grouped into small hard drusen, soft drusen, and retic-
ular pseudodrusen. Small hard drusen were defined as drusen
smaller than 63 μm, and soft drusen were defined as drusen
that were 63 μm or larger with round and soft borders.
Reticular pseudodrusen were defined as drusenoid deposits
with a yellowish interlacing network on fundus photography,
hypofluorescence on infrared reflectance images, and evi-
dence of corresponding sub-retinal deposits on OCT
[18–21]. Pigmentary change was defined as depigmentation
or reactive hyperpigmentation with a size larger than 1/8 disc
diameter on fundus photography (Fig. 2b, c, d). The propor-
tions of eyes with these findings were evaluated in each group.
Evaluation of spectral domain optical coherence
tomography images
The presence of a double layer sign, elevation by DLD or soft
drusen, elevation by pigment epithelial detachment, and
disruption of the retinal pigment epithelial layer due to pigmen-
tary change were evaluated on OCT. A double layer sign was
defined as two highly reflective layers visible at the retinal pig-
ment epithelium (Fig. 2d) [22, 23]. Elevation by DLD or soft
drusen was defined as elevation over the nearby interdigitation
zone line, formerly called the cone outer segment tip line [24],
on OCT in the area of DLD or soft drusen. The criterion for
defining elevation by pigment epithelial detachment was eleva-
tion over the nearby interdigitation zone line by serous pigment
epithelial detachment. Disruption of the retinal pigment epithe-
lial layer due to pigmentary change was defined as retinal pig-
ment epithelial layer disruption on the OCT scan of the area of
pigmentary change on fundus photography.
Evaluation of indocyanine green angiography images
In Groups 1 and 2, the presence of choroidal hyperpermeability,
punctate hyperfluorescence spots, and late geographic
hyperfluorescence on ICGAwere evaluated in all eyes. The spa-
tial correlation of punctate hyperfluorescence spots and choroidal
hyperpermeability or DLD was evaluated. Choroidal
hyperpermeability was defined as multifocal hyperfluorescent
areas with blurred margins after a gradual increase in choroidal
hyperfluorescence intensity 10 minutes after infusion of indocy-
anine green [9]. Punctate hyperfluorescence spots were defined
as punctate hyperfluorescence in the mid- to late phase of ICGA
(Fig. 1c) [25]. The number of punctate hyperfluorescence spots
was grouped into 2 or less, 3 to 10, 11 to 20, 21 to 40, or more
than 40. Late geographic hyperfluorescence was defined as
hyperfluorescent lesions with a clearly demarcated geographic
margin about 10 minutes after injection of indocyanine green
dye [26].
Statistical analysis
Statistical analysis was performed using SPSS software ver-
sion 18.0 (SPSS, Inc., Chicago, IL, USA). To identify whether
there was any difference between the three groups, we con-
ducted analysis of variance (ANOVA) for continuous vari-
ables and chi-square test for non-continuous variables. P value
less than 0.05 is considered significant.
If the above analysis confirmed any significant difference, a
comparison between two groups was then conducted by inde-
pendent Student’s T-test for continuous variables and Fisher’s
exact test for non-continuous variables. A P value less than
0.016 after Bonferroni correction was considered significant.
Results
The study included 154 eyes of 154 unilateral PCV patients in
Group 1, 59 eyes of 59 unilateral typical exudative AMD
patients in Group 2, and 63 eyes of 63 unilateral ERM patients
Fig. 2 Funduscopic and optical coherence tomographic (OCT) images in
the unaffected fellow eyes of patients with unilateral polypoidal choroidal
vasculopathy are presented. All cases are fromGroup 1. (a, b) These eyes
show drusen-like deposits (DLD, arrows) and pigmentary changes (solid
arrow heads). There are DLDs represented by yellowish deposits with
irregular but discrete margins. The DLD manifests as an amorphous
subretinal deposit usually disrupting the ellipsoid zone on OCT. OCT
manifestations of pigmentary changes range from mild attenuation in
the interdigitation zone (a) to severe disruption in the outer retina
involving the ellipsoid zone and even the external limiting membrane
(b). Choroidal thickening is remarkable in both cases. (c, d) These eyes
show only pigmentary changes on funduscopy. The third row case
exhibits mild disruption in the interdigitation zone and retinal pigment
epithelium/Bruch’s complex on OCT. In contrast, a double layer sign
(open arrow heads) on OCT is conspicuous in the fourth row case. (e)
In a significant proportion of eyes in Group 1, no specific abnormality
was noted, as in this case
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in Group 3. The mean age was 67.2 ± 8.1 years in Group 1,
71.6 ± 8.9 years in Group 2, and 66.9 ± 9.4 years in Group 3
(Table 1). There was no statistical difference in age between
Group 1 and Group 3, which was the age-matched control
group (p = 0.182). There were significantlymoremale patients
in Group 1 compared to Groups 2 and 3 (p = 0.005 and
p < 0.001, respectively) (Table 1).
Fundus photographic findings
On analysis of the frequency of drusen in each group, soft
drusen and reticular pseudodrusen were both more common
in Group 2 than Groups 1 and 3 (p < 0.001) (Table 2). The
frequency of small hard drusen was not different between
groups (p = 0.09). DLDs were found in the highest frequency
in Group 1 (24.7 %), which was significantly higher than in
Groups 2 and 3 (p < 0.001 and p = 0.015, respectively). Also,
DLDs of 125 μm or larger were found in 19.5, 3.4, and 3.2 %
of patients in Groups 1 through 3, respectively, with a signif-
icantly larger percentage found in Group1 (p = 0.002 and
p = 0.001, respectively) (Table 2). The DLDs were usually
heterogeneous in size within a given eye, and their distribution
was usually not central (Figs. 1a and 2a, b). There was no
significant difference in presence of DLDs between Groups
2 and 3 (p = 0.275). The frequency of pigmentary change was
39.6, 35.6, and 14.3 % in Groups 1 through 3, respectively.
Group 3 showed significantly less pigmentary change than the
other two groups (p < 0.001 and p = 0.011, respectively).
Optical coherence tomography findings
A double layer sign was found in 9.1, 10.2, and 0.0 % of eyes
in Groups 1, Group 2, and Group 3, respectively, and was
significantly less frequent in Group 3 than Groups 1 and 2
(p = 0.012 and p = 0.011, respectively) (Table 3). Elevation
by DLD or soft drusen was found in 16.9, 37.3, and 1.6 %
of eyes from each group, respectively, and was significantly
less frequent in Group 3 than Groups 1 and 2 (p = 0.001 and
p < 0.001, respectively). Elevation due to DLD was usually
accompanied by disruption of the ellipsoid zone in the corre-
sponding area, and there was a certain degree of hyper reflec-
tivity in the inner borders of DLDs. In contrast to soft drusen,
the DLDs usually manifests as asymmetric or triangular-
shaped subretinal deposits on OCT (Fig. 2a, b). Elevation by
pigment epithelial detachment was found in 5.8, 8.5, and 0 %
of each group, respectively, and was significantly more com-
mon in Group 2 compared to Group 3 (p = 0.024). Disruption
of the retinal pigment epithelial layer due to pigmentary
change was found in 4.5, 8.5, and 1.6 %, respectively, with
no significant difference among the groups.
The mean subfoveal choroidal thicknesses in the eyes of
Groups 1 to 3 was 261.4 ± 99.0, 178.2 ± 101.0, and 207.4
± 77.6 μm, respectively. The thickness in Group 1 was signif-
icantly greater than those of Groups 2 and 3 (p < 0.001, <
0.001, respectively). The thickness of Group 2 tended to be
less than that of Group 3, although this difference was not
statistically significant (p = 0.080) (Table 3).
Indocyanine green angiography findings
On comparison of ICGA findings of Group 1 and 2, choroidal
hyperpermeability was found in 23.4 and 6.8 % of eyes, respec-
tively, andwas significantly more frequent in Group 1 compared
to Group 2 (p = 0.005) (Table 4). The number of punctate
hyperfluorescence spots was not different among the two groups
(p = 0.647). Late geographic hyperfluorescencewas found in 9.7
and 1.7 % of eyes in Groups 1 and 2, respectively (p = 0.076).
Spatially correlated DLDs and punctate hyperfluorescence spots
were found in 18.2 % of eyes in Group 1, and 0 % of Group 2
(p < 0.001) (Fig. 1e). Spatially correlated punctate
hyperfluorescence spots and choroidal hyperpermeability were
found in 8.4 % of eyes in Group 1 and 5.1 % of Group 2
(p = 0.565).
Table 1 Basic demographic
characteristics of the study
subjects
Group 1 Group 2 Group 3 Overall P value* P value† P value‡ P value**
N (eyes) 154 59 63
Age (years) 67.2 ± 8.1 71.6 ± 8.9 66.9 ± 9.4 0.002 0.182 0.006 0.001
M : F 2.2:1 0.9:1 0.7:1 <0.001 <0.001 0.465 0.005
Group 1: fellow eye of unilateral polypoidal choroidal vasculopathy; Group 2: fellow eye of unilateral typical
exudative age-related macular degeneration; Group 3: fellow eye of unilateral epiretinal membrane, as a control
* comparison of all Groups, by ANOVA for continuous variables and chi-square test for non-continuous vari-
ables. P value less than 0.05 is considered significant
The independent Student’s T-test was used for the comparison of age, and Fisher’s exact test was used for the
comparison of gender in each group. P value less than 0.016 after Bonferroni correction is considered significant
† comparison of Groups 1 and 3
‡ comparison of Groups 2 and 3
** comparison of Groups 1 and 2
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Discussion
In this study, the uninvolved fellow eyes of active PCV or
typical exudative AMD patients were studied. The bilateral
PCV has been reported in about 15 % of cases [4, 7, 15, 27],
and the probability of exudation in the fellow eye in
neovascular AMD is at least 13 % [28]. The probability of
the fellow eye developing the same disease in unilateral cases
Table 3 Frequency of spectral
domain optical coherence
tomography findings in each
group








N. of participants 154 59 63
Double layer
sign




16.9 % 37.3 % 1.6 % <0.001 0.001 <0.001 0.003
Elevation by
PED
5.8 % 8.5 % 0.0 % 0.049 0.062 0.024 0.539
Disruption of
RPE
4.5 % 8.5 % 1.6 % 0.203
Choroidal
thickness, μm
261.4 ± 99.0 178.2 ± 101.0 207.4 ± 77.6 <0.001 <0.001 0.080 <0.001
Group 1: fellow eye of unilateral polypoidal choroidal vasculopathy; Group 2: fellow eye of unilateral typical
exudative age-related
macular degeneration; Group 3: fellow eye of unilateral epiretinal membrane, as a control
DLD, drusen-like deposits; PED, pigment epithelial detachment; RPE, retinal pigment epithelium
* comparison of all Groups; P value less than 0.05 is considered significant
† comparison of Groups 1 and 3; P value less than 0.016 is considered significant
‡ comparison of Groups 2 and 3; P value less than 0.016 is considered significant
** comparison of Groups 1 and 2; P value less than 0.016 is considered significant
Table 2 Frequency of




















33.8 % 27.1 % 19.0 % 0.091
RPD 0.6 % 22.0 % 1.6 % <0.001 0.497 <0.001 <0.001
Soft drusen 4.5 % 25.4 % 8.0 % <0.001 0.110 <0.001 <0.001
Presence of DLD 24.7 % 3.4 % 9.5 % <0.001 0.015 0.275 <0.001
Size of DLD <0.001 0.001 1.000 0.002
<125 μm 80.5 % 96.6 % 96.8 %
> 125 μm 19.5 % 3.4 % 3.2 %
Pigmentary
changes
39.6 % 35.6 % 14.3 % 0.001 <0.001 0.011 0.639
Group 1: fellow eye of unilateral polypoidal choroidal vasculopathy; Group 2: fellow eye of unilateral typical
exudative age-related macular degeneration; Group 3: fellow eye of unilateral epiretinal membrane, as a control
Drusen-like deposits (DLD) were defined as sub-retinal or sub-retinal pigment epithelial grayish yellow deposits
larger than 63 μm in size with irregular but discrete margins
RPD: reticular pseudodrusen
* comparison of all Groups; P value less than 0.05 is considered significant
† comparison of Groups 1 and 3; P value less than 0.016 is considered significant
‡ comparison of Groups 2 and 3; P value less than 0.016 is considered significant
** comparison of Groups 1 and 2; P value less than 0.016 is considered significant
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of active exudative maculopathy is higher than 1.2 % [29],
which is the incidence in the general population. Previous
reports also indicate that the diagnosis in the fellow eyes, if
involved, is almost always the same subtype of neovascular
AMD [4, 15]. Therefore, studying changes in the uninvolved
fellow eye without active exudative maculopathy might be an
effective method of evaluating precursor lesions of these
diseases.
One of the major findings of this study was that soft
drusen and reticular pseudodrusen were more common in
Group 2, the typical exudative AMD group, than the normal
control Group 3. This supports the previously well-known
finding that soft drusen and reticular pseudodrusen are early
precursor lesions of typical exudative AMD, and further
supports the validity of this study method. Soft drusen and
reticular pseudodrusen were found significantly more often
in Group 2 than in Group 1, the PCV group, while there
was no significant difference between Groups 1 and 3.
Therefore, soft drusen and reticular pseudodrusen are un-
likely to be precursor lesions of PCV. This might also serve
as evidence that PCV has a different pathophysiologic
mechanism from typical exudative AMD. DLD, especially
those larger than 125 μm, were found significantly more
often in the PCV group than the control group or exudative
AMD group. Also, the frequency of DLD was not different
between the typical exudative AMD group and the control
group. In other words, soft drusen and reticular
pseudodrusen can be thought of as early precursor lesions
heralding the development of late exudative AMD, while
DLD (especially large lesions) can be thought of as the early
precursor lesion of PCV.
In this study, DLD was defined as a sub-retinal or sub-
retinal-pigment-epithelial grayish yellow deposit of 63 μm
or larger in size with irregular but discrete margins. The largest
difference between DLD and typical drusen on funduscopy is
the irregularity of the margin, which might result from clus-
tering of smaller deposits at the margins of previous lesions
(Fig. 3). Comparedwith true drusen, DLD exhibits a relatively
large size with a non-circular and irregular margin and often
accompanies pigmentary changes.
After reporting a case series of pachychoroid pigment
epitheliopathy that manifested drusen-like lesions and a thick
choroid [30], Freund and associates have proposed the exis-
tence of a pachychoroid pigment epitheliopathy—
pachychoroid neovasculopathy—PCV axis [31]. DLD ob-
served in the present study are possibly the same lesions as
they termed drusen-like lesions. The present results of Group
1 eyes showing DLD, choroidal hyperpermeability, and cho-
roidal thickening further support their hypothesis. DLDs are
accompanied by pigmentary changes and yellowish sub-
retinal precipitates that are composed of macrophages and
outer segment photoreceptor shedding [32, 33]. The initially
dot-like precipitates become confluent and increase in size,
and the irregular margins of DLDs observed in the current
study might be produced by the confluence of these dot-like
precipitates. Also, in Group 1, the spatial correlation of punc-
tate hyperfluorescence spots and DLDs was confirmed, fur-
ther supporting this developmental mechanism of DLD.
A double layer sign, elevation due to DLD or soft drusen,
and disruption of the retinal pigment epithelial layer due to
pigmentary change were found in significantly higher fre-
quencies on OCT in Group 1 than in the control Group. In
Table 4 Indocyanine green








N. of participants 154 59
Choroidal hyperpermeability 23.4 % 6.8 % 0.005
Punctate hyperfluorescence spot
0–2 23.4 % 28.8 % 0.647
3–10 20.8 % 23.7 %
10–20 27.3 % 18.6 %
20–40 19.5 % 16.9 %
>40 9.1 % 11.9 %
Late geographic hyperfluorescence 9.7 % 1.7 % 0.076
Spatially correlated punctate hyperfluorescence spots and DLD 18.2 % 0.0 % <0.001
Spatially correlated punctate hyperfluorescence spots and choroidal
hyperpermeability
8.4 % 5.1 % 0.565
Group 1: fellow eye of unilateral polypoidal choroidal vasculopathy; Group 2: fellow eye of unilateral typical
exudative
age-related macular degeneration; Group 3: fellow eye of unilateral epiretinal membrane, as a control
DLD, drusen-like deposits
† comparison of Groups 1 and 2
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contrast to soft drusen, the DLDs usually manifest as asym-
metric or triangular-shaped subretinal deposits with a certain
degree of hyper reflectivity on OCT. Because sub-retinal or
sub-retinal-pigment-epithelial deposits including DLD were
associated with macular diseases other than AMD, it can be
difficult to differentiate funduscopically from true drusen,
OCT is useful for differentiating DLD and drusen and for
evaluating choroidal thickening. In previous reports, drusen
were not an uncommon finding in PCV [4, 34]. It is possible
that a significant proportion of drusen described in previous
studies of PCV might have been DLD. As OCT is useful for
differentiating DLD and true drusen, it might contribute to
identifying the precursor lesions of PCV, especially when
combined with fundus autofluorescence imaging.
Identifying the precursor lesion of PCV has various impli-
cations. First, the pathophysiological process can be identified
and addressed before the development of active PCV via sys-
temic or genomic studies. Second, proper disease staging, in-
struction, and surveillance of early lesions will be possible.
Third, treatment methods to delay or prevent progression
might be developed through further studies of high-risk
groups. Based on the results of this study, a nation-wide cohort
study to identify the real risk of developing active PCV in
subjects with DLDs and pigmentary changes is currently be-
ing launched.
This study has several limitations. First, patients with
PCV were recruited from seven referral hospitals to secure
a sufficient number of unequivocal cases. Eyes with typi-
cal exudative AMD or ERM were enrolled from a reading
center. Thus, the numbers in Group 1 and Group 2 do not
reflect the actual prevalence of exudative AMD subtypes
in Asia [4, 5]. However, we did not expect this to signif-
icantly affect the main results of the current study. Second,
this study was a multi-center, cross-sectional study in
which heterogeneous equipment for angiography and
spectral domain OCT was involved. Third, some OCT
scans were limited in use for evaluating DLD or pigmen-
tary changes, and this might have affected the results.
Despite these limitations, this study is significant because
it included a relatively large number of uninvolved fellow
eyes of unilateral PCV cases, and, as far as the authors are
aware, this is the first study to suggest DLD as the precur-
sor lesion of PCV.
In conclusion, this study suggests that pigmentary
change and sub-retinal or sub-retinal-pigment-epithelial
grayish yellow deposits with an irregular margin (DLD)
are early precursor lesions of PCV. In particular, DLDs
larger than 125 μm in size are specific precursor lesions
of PCV. These lesions may have been formed from previ-
ous subclinical or chronic inactive central serous
chorioretinopathy. Further large-scale longitudinal studies
are needed to confirm this conclusion.
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Fig. 3 Funduscopic and optical coherence tomographic (OCT) images
comparing drusen-like deposits (DLD, a, b) and soft drusen (c, d).
Compared with soft drusen, DLD exhibits a relatively larger size with a
non-circular and irregular margin. Asymmetric distribution between two
eyes also characterizes DLD. DLD manifests as an amorphous subretinal
deposit usually disrupting the ellipsoid zone on OCT
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